DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $13.54 Average PT from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received an average recommendation of “Hold” from the fifteen ratings firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $13.5385.

Several brokerages have recently weighed in on XRAY. Piper Sandler increased their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Barclays increased their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a research report on Monday, August 10th. Finally, BMO Capital Markets restated a “market perform” rating and issued a $13.00 price target on shares of DENTSPLY SIRONA in a report on Friday, August 7th.

Insider Activity at DENTSPLY SIRONA

In related news, Director Brian Gladden acquired 9,985 shares of the stock in a transaction on Monday, June 15th. The stock was bought at an average cost of $10.02 per share, with a total value of $100,049.70. Following the transaction, the director directly owned 61,849 shares in the company, valued at approximately $619,726.98. This represents a 19.25% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Michael Barber bought 15,175 shares of the company’s stock in a transaction on Thursday, June 11th. The stock was bought at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the completion of the purchase, the director directly owned 55,943 shares in the company, valued at approximately $552,716.84. This represents a 37.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 35,160 shares of company stock worth $351,179 in the last 90 days. 0.46% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth $26,000. Eurizon Capital SGR S.p.A. purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at $26,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares in the last quarter. Nykredit A S bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $38,000. Finally, Farther Finance Advisors LLC lifted its stake in DENTSPLY SIRONA by 119.1% in the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after acquiring an additional 2,051 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $11.38 on Wednesday. DENTSPLY SIRONA has a 12 month low of $9.40 and a 12 month high of $14.86. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. The company has a 50-day moving average price of $12.16 and a 200 day moving average price of $11.67. The stock has a market cap of $2.27 billion, a PE ratio of -4.14, a P/E/G ratio of 1.45 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.4 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.